P1.25. Real-World Data of Completely Resected Lung Adenocarcinoma Harboring Common EGFR Mutation in Japan (CReGYT-01 EGFR study) - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Shinya Katsumata
Meta Tag
Speaker Shinya Katsumata
Topic Early-Stage NSCLC: Changing Paradigms & Outcomes
WCLC 2023 conference
post-relapse treatment
lung adenocarcinoma
EGFR mutation
adjuvant therapy
retrospective study
tyrosine kinase inhibitors
real-world settings
Powered By